Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated:  1/23/2013
mi
from
Los Angeles, CA
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated:  1/23/2013
mi
from
Centennial, CO
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
IMMUNOe International Reseach Centers
mi
from
Centennial, CO
Click here to add this to my saved trials
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated:  1/23/2013
mi
from
Atlanta,, GA
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
Family Allergy and Asthma Center, PC
mi
from
Atlanta,, GA
Click here to add this to my saved trials
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated:  1/23/2013
mi
from
Chicago, IL
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated:  1/23/2013
mi
from
Pittsburgh, PA
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated:  1/23/2013
mi
from
Irving, TX
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
Allergy, Asthma & Immunology Clinic, P.A.
mi
from
Irving, TX
Click here to add this to my saved trials
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated:  1/23/2013
mi
from
Layton, UT
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
Rocky Mountain Allergy, Asthma & Immunology
mi
from
Layton, UT
Click here to add this to my saved trials
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated:  1/23/2013
mi
from
Richmond, VA
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
A Phase IV, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases (PID) in Children and Adolescents
Status: Enrolling
Updated: 1/23/2013
Children's Hospital of Richmond, VA
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study of the Activity of Eculizumab for Prevention of Delayed Graft Function In Deceased Donor Kidney Transplant
Pilot Study of the Clinical Activity of Eculizumab for Prevention of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  1/25/2013
mi
from
New York, NY
A Study of the Activity of Eculizumab for Prevention of Delayed Graft Function In Deceased Donor Kidney Transplant
Pilot Study of the Clinical Activity of Eculizumab for Prevention of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 1/25/2013
Mount Sinai Recanati/Miller Transplantation Institute
mi
from
New York, NY
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated:  1/25/2013
mi
from
Phoenix, AZ
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated:  1/25/2013
mi
from
Santa Clara, CA
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated:  1/25/2013
mi
from
Aurora, CO
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated:  1/25/2013
mi
from
Daytona Beach, FL
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated:  1/25/2013
mi
from
Addison, IL
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Ocean Spray Cranberries Research Sites
mi
from
Addison, IL
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated:  1/25/2013
mi
from
Park Ridge, IL
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated:  1/25/2013
mi
from
Rochester, MN
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated:  1/25/2013
mi
from
Cleveland, OH
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated:  1/25/2013
mi
from
Charleston, SC
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated:  1/25/2013
mi
from
Dallas, TX
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated:  1/25/2013
mi
from
Salt Lake City, UT
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Status: Enrolling
Updated: 1/25/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated:  1/31/2013
mi
from
Gainesville, FL
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated: 1/31/2013
University of Florida College of Medicine
mi
from
Gainesville, FL
Click here to add this to my saved trials
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated:  1/31/2013
mi
from
Kansas City, KA
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated: 1/31/2013
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated:  1/31/2013
mi
from
Louisville, KY
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated: 1/31/2013
Advanced ENT & Allergy
mi
from
Louisville, KY
Click here to add this to my saved trials
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated:  1/31/2013
mi
from
Morristown, NJ
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated: 1/31/2013
Summit Medical Group
mi
from
Morristown, NJ
Click here to add this to my saved trials
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated:  1/31/2013
mi
from
Winston-Salem, NC
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Status: Enrolling
Updated: 1/31/2013
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated:  2/18/2013
mi
from
Los Angeles, CA
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated: 2/18/2013
Pfizer Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated:  2/18/2013
mi
from
Bridgeport, CT
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated: 2/18/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
Click here to add this to my saved trials
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated:  2/18/2013
mi
from
Atlantis, FL
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated: 2/18/2013
Pfizer Investigational Site
mi
from
Atlantis, FL
Click here to add this to my saved trials
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated:  2/18/2013
mi
from
Baltimore, MD
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated: 2/18/2013
Pfizer Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated:  2/18/2013
mi
from
Houston, TX
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss
Status: Enrolling
Updated: 2/18/2013
Pfizer Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Nutrition, Exercise, and Breast Cancer Survivorship
Impact of Nutrition and Exercise on Glucose Metabolism, Inflammation, and Body Composition in Older Breast Cancer Survivors
Status: Enrolling
Updated:  2/21/2013
mi
from
Baltimore, MD
Nutrition, Exercise, and Breast Cancer Survivorship
Impact of Nutrition and Exercise on Glucose Metabolism, Inflammation, and Body Composition in Older Breast Cancer Survivors
Status: Enrolling
Updated: 2/21/2013
Baltimore VAMC
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated:  2/22/2013
mi
from
Phoenix, AZ
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated: 2/22/2013
Arizona Burn Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated:  2/22/2013
mi
from
Orlando, FL
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated: 2/22/2013
Orlando Regional Medical Center
mi
from
Orlando, FL
Click here to add this to my saved trials
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated:  2/22/2013
mi
from
Indianapolis, IN
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated: 2/22/2013
Wishard
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated:  2/22/2013
mi
from
Oklahoma City, OK
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated: 2/22/2013
Paul Silverstein, MD
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated:  2/22/2013
mi
from
Philadelphia, PA
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated: 2/22/2013
S:t Christopher's Hospital for Children
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated:  2/22/2013
mi
from
Seattle, WA
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.
Status: Enrolling
Updated: 2/22/2013
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
An Observational Prospective Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Status: Enrolling
Updated:  2/28/2013
mi
from
Oakland, CA
Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
An Observational Prospective Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Status: Enrolling
Updated: 2/28/2013
Children's Hospital and Research Center
mi
from
Oakland, CA
Click here to add this to my saved trials
Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
An Observational Prospective Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Status: Enrolling
Updated:  2/28/2013
mi
from
Minneapolis, MN
Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
An Observational Prospective Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Status: Enrolling
Updated: 2/28/2013
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
mi
from
Phoenix, AZ
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
mi
from
Upper San Gabriel Valley, CA
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
City of Hope
mi
from
Upper San Gabriel Valley, CA
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
mi
from
Long Beach, CA
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Miller Children's Hospital
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
mi
from
Los Angeles, CA
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
mi
from
Madera, CA
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Children's Hospital Central California
mi
from
Madera, CA
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
mi
from
Oakland, CA
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Oakland Children's Hospital
mi
from
Oakland, CA
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
mi
from
Stanford, CA
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
mi
from
San Francisco, CA
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
UCSF School of Medicine
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
mi
from
Aurora, CO
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
The Children's Hospital, University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
mi
from
Miami, FL
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
University of Miami Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated:  3/11/2013
mi
from
Atlanta, GA
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Children's Healthcare of Atlanta/Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials